GelStat Corporation
GSAC
Rank in Stocks
#32962
GelStat Corporation operates as a consumer healthcare enterprise, specializing... GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.
Share Price
$0.0003
Last synced: 2026-11-10
Market Cap
$919.63K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade GelStat Corporation (GSAC)
Category
Healthcare
Operating Margin for GelStat Corporation (GSAC)
Operating Margin as of November 2026 TTM: -90.26%
According to GelStat Corporation's latest financial reports, its current operating margin (TTM) is -90.26%. At the end of 2025 the company had an operating margin of -90.26%.
Operating Margin history for GelStat Corporation from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -90.26% | 0.00% |
| 2025 | -90.26% | 12.33% |
| 2024 | -80.35% | -27.55% |
| 2023 | -110.90% | -99.57% |
| 2022 | -25,803.69% | 478.89% |
| 2021 | -4,457.42% | -0.83% |
| 2020 | -4,494.86% | -5,262.95% |
| 2019 | 87.06% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2014 | -99.16% | -96.15% |
| 2013 | -2,578.56% | 36.54% |
| 2012 | -1,888.46% | -75.66% |
| 2011 | -7,758.26% | -37.58% |
| 2010 | -12,428.84% | 9,872.59% |
| 2009 | -124.63% | -93.14% |
| 2008 | -1,815.89% | -68.26% |
| 2007 | -5,721.20% | 660.15% |
| 2006 | -752.64% | -53.77% |
| 2005 | -1,627.92% | -34.00% |
| 2004 | -2,466.41% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | -100.00% |
| 2001 | -6,323.72% | 631.95% |
| 2000 | -863.95% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.69% | -100.22% |
DE
|
|
| 19.68% | -100.22% |
DE
|
|
| 13.26% | -100.15% |
JP
|
|
| 17.08% | -100.19% |
CH
|
|
| 10.53% | -100.12% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about GelStat Corporation's operating margin
What is GelStat Corporation's operating margin?
GelStat Corporation's operating margin is -90.26%, as of Nov 2026.
What was GelStat Corporation's operating margin in 2025?
In 2025, GelStat Corporation's operating margin was -90.26%, compared with -80.35% in 2024.
How has GelStat Corporation's operating margin changed since 2020?
From 2020 to 2025, GelStat Corporation's operating margin was highest in 2024 (-80.35%) and lowest in 2022 (-25,803.69%).
How does GelStat Corporation's operating margin compare with similar companies?
GelStat Corporation's operating margin (-90.26%) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.